Skip to content
10-K

Annual Report

BioCorRx Inc. BICX

0001477932-26-001807

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 27, 2026 26.4M sh
Shares Diluted FY 2025 · Dec 31, 2025 18.49M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 10.46M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$2.3M
Operating Cash Flow FY 2025 · Sep 30, 2025 −$1.45M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$1.1M
Stockholders Equity FY 2025 · Dec 31, 2025 −$11.22M
Stockholders Equity FY 2025 · Dec 31, 2024 −$12.12M
Current Liabilities FY 2025 · Dec 31, 2025 $8.31M
Current Liabilities FY 2025 · Dec 31, 2024 $8.21M
Total Liabilities FY 2025 · Dec 31, 2025 $13.67M
Total Liabilities FY 2025 · Dec 31, 2024 $12.74M
Current Assets FY 2025 · Dec 31, 2025 $814.47K
Current Assets FY 2025 · Dec 31, 2024 $118K
Total Assets FY 2025 · Dec 31, 2025 $2.15M
Total Assets FY 2025 · Dec 31, 2024 $385.94K
Eps Diluted FY 2025 · Dec 31, 2025 −$0.19
Eps Diluted FY 2025 · Dec 31, 2024 −$0.49
Sga Expense FY 2025 · Dec 31, 2025 $3.79M
Sga Expense FY 2025 · Dec 31, 2024 $3.61M
Rd Expense FY 2025 · Dec 31, 2025 $1.77M
Rd Expense FY 2025 · Dec 31, 2024 $1.48M
Net Income FY 2025 · Dec 31, 2025 −$3.44M
Net Income restated FY 2025 · Dec 31, 2024 −$5.11M
Operating Income FY 2025 · Dec 31, 2025 −$4.83M
Operating Income FY 2025 · Dec 31, 2024 −$5.12M
Revenue FY 2025 · Dec 31, 2025 $797.24K
Revenue FY 2025 · Dec 31, 2024 $7.67K